VUS was detected in two (2/8; 25%) patients with TNBC, two patients (2/8; 25%) with luminal B breast cancer, one patient (1/8; 12.5%) with luminal A and one patient (1/8; 12.5%) with a HER2+ tumor. Here, ERBB2 is linked to breast cancer.